Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 90 articles: HTML format

Single Articles

September 2024
1. KETCHEM CJ
   The Impact of Population-Based Helicobacter pylori Test-To-Treat Strategies on Gastric Cancer Outcomes.
   Gastroenterology. 2024 Sep 25:S0016-5085(24)05528.
   PubMed    
   
   
   August 2024
2. OH HN, Sul WJ, Son SY, Han SU, et al
   Effect of enterotype-dependent stability of the gut microbiome on post-gastrectomy malnutrition in gastric cancer patients.
   Gastroenterology. 2024 Aug 14:S0016-5085(24)05347.
   PubMed    
   
   
   
3. ZHAO JJ, Johnny Ong CA, Srivatsava S, Ann Chia DK, et al
   Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases.
   Gastroenterology. 2024 Aug 13:S0016-5085(24)05348.
   PubMed     Abstract available
   
   
   
4. ARIMURA S, To S, Mills JC
   Changing Fate: How EGFRs "Pit" Cell Versus Cell in the Stomach.
   Gastroenterology. 2024;167:441-442.
   PubMed    
   
   
   
5. CHENG X, Dai E, Wu J, Flores NM, et al
   Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response.
   Gastroenterology. 2024 Aug 1:S0016-5085(24)05297.
   PubMed     Abstract available
   
   
   July 2024
6. MULE P, Fernandez-Perez D, Amato S, Manganaro D, et al
   WNT Oncogenic Transcription Requires MYC Suppression of Lysosomal Activity and EPCAM Stabilization in Gastric Tumours.
   Gastroenterology. 2024 Jul 4:S0016-5085(24)05182.
   PubMed     Abstract available
   
   
   June 2024
7. HU C, You W, Kong D, Huang Y, et al
   Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13(+)CD103(+)CD8(+) Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.
   Gastroenterology. 2024;166:1069-1084.
   PubMed     Abstract available
   
   
   April 2024
8. ARAI J, Hayakawa Y, Tateno H, Murakami K, et al
   Impaired glycosylation of gastric mucins drives gastric tumorigenesis and serves as a novel therapeutic target.
   Gastroenterology. 2024 Apr 5:S0016-5085(24)00363.
   PubMed     Abstract available
   
   
   
9. AIHARA H, Draganov PV
   Does a Rising Tide Lift All Boats? How Institutional Procedural Volume Impacts the Clinical Outcomes of Gastric Endoscopic Submucosal Dissection.
   Gastroenterology. 2024;166:561-563.
   PubMed    
   
   
   
10. PARK JY, Kim MS, Kim BJ, Kim JG, et al
    Influence of Procedural Volume on the Outcome of Gastric Endoscopic Submucosal Dissection: A Nationwide Population-Based Study Using Administrative Data.
    Gastroenterology. 2024;166:680-689.
    PubMed     Abstract available
    
    
    March 2024
11. XU J, Deng M, Tang X
    Comments on "Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022".
    Gastroenterology. 2024 Mar 15:S0016-5085(24)00294.
    PubMed    
    
    
    
12. SHIRATORI Y, Ishii N, Kalloo A
    Disparities in Gastric Cancer Screening: A Comparative Analysis of Japan and South Korea.
    Gastroenterology. 2024 Mar 15:S0016-5085(24)00296.
    PubMed    
    
    
    
13. LI GF, Qiao YW, Yu G
    Helicobacter pylori Therapy and Risk of Gastric Cancer After Endoscopic Resection of Dysplasia: A Sensitivity Analysis Assessing Impact of Unmeasured Confounding.
    Gastroenterology. 2024 Mar 14:S0016-5085(24)00292.
    PubMed    
    
    
    
14. LU SY, Zhang H, Chen Y
    Refractory Diarrhea and Gastric Adenocarcinoma, Just a Coincidence?
    Gastroenterology. 2024;166:e1-e5.
    PubMed    
    
    
    February 2024
15. UCHIYAMA T, Saito H, Nishikawa Y
    Lessons from Japan's Case for Early Helicobacter pylori Screening.
    Gastroenterology. 2024 Feb 29:S0016-5085(24)00245.
    PubMed    
    
    
    
16. SHIRATORI Y, Ishii N, Kalloo A
    Metachronous Gastric Cancer Outcomes Following H-pylori Therapy after Endoscopic Dysplasia Resection: Insights from a Global Real-World Study.
    Gastroenterology. 2024 Feb 18:S0016-5085(24)00176.
    PubMed    
    
    
    January 2024
17. WON Y, Jang B, Lee SH, Reyzer ML, et al
    Oncogenic fatty acid metabolism rewires energy supply chain in gastric carcinogenesis.
    Gastroenterology. 2024 Jan 23:S0016-5085(24)00064.
    PubMed     Abstract available
    
    
    
18. CHEN YC, Malfertheiner P, Yu HT, Kuo CL, et al
    Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022.
    Gastroenterology. 2024 Jan 2:S0016-5085(23)05687.
    PubMed     Abstract available
    
    
    December 2023
19. SHAH SC, Boeder S, Piazuelo MB, Li D, et al
    The Stomach Looks Suspicious, But Is It Pernicious?
    Gastroenterology. 2023;165:1342-1351.
    PubMed    
    
    
    
20. RUBENSTEIN JH, Fontaine S, MacDonald PW, Burns JA, et al
    Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health Records.
    Gastroenterology. 2023;165:1420-1429.
    PubMed     Abstract available
    
    
    November 2023
21. SUN D, Mulder DT, Li Y, Nieboer D, et al
    The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: a Synthetic Control Study.
    Gastroenterology. 2023 Nov 23:S0016-5085(23)05562.
    PubMed     Abstract available
    
    
    
22. MURUAGA EJ, Jones NL
    Helicobacter pylori genetic variations: A driver of gastric cancer progression?
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05226.
    PubMed    
    
    
    
23. CHEN YY, Chang HM, Chen CH
    A Rare Cause of Duodenal ulcer.
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05225.
    PubMed    
    
    
    
24. FORD AC, Graham DY
    Toward quantification of H. pylori-associated gastric cancer risk: Further evidence supporting development of population-based strategies for H. pylori eradication.
    Gastroenterology. 2023 Nov 2:S0016-5085(23)05203.
    PubMed    
    
    
    October 2023
25. YOO HW, Hong SJ, Kim SH
    Helicobacter pylori Treatment and Gastric Cancer Risk after Endoscopic Resection of Dysplasia: A Nationwide Cohort Study.
    Gastroenterology. 2023 Oct 18:S0016-5085(23)05140.
    PubMed     Abstract available
    
    
    
26. MOSS SF, Shah SC, Tan MC, El-Serag HB, et al
    Evolving Concepts in Helicobacter pylori management.
    Gastroenterology. 2023 Oct 6:S0016-5085(23)05083.
    PubMed     Abstract available
    
    
    
27. KIM H, Jang B, Zhang C, Caldwell B, et al
    Targeting Stem Cells and Dysplastic Features with Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis.
    Gastroenterology. 2023 Oct 4:S0016-5085(23)05075.
    PubMed     Abstract available
    
    
    
28. LIU R, Dai Z, Zhang F, Zhu C, et al
    An Unusual Cause of Gastric Masses.
    Gastroenterology. 2023;165:834-837.
    PubMed    
    
    
    August 2023
29. SUGANO K, Moss SF, Kuipers EJ
    Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
    Gastroenterology. 2023 Aug 29:S0016-5085(23)04911.
    PubMed     Abstract available
    
    
    
30. LEE SH, Contreras Panta EW, Gibbs D, Won Y, et al
    Apposition of Fibroblasts With Metaplastic Gastric Cells Promotes Dysplastic Transition.
    Gastroenterology. 2023;165:374-390.
    PubMed     Abstract available
    
    
    July 2023
31. LI G, Chen H, Ren C
    The SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated.
    Gastroenterology. 2023 Jul 4:S0016-5085(23)00951.
    PubMed    
    
    
    
32. CHEN J, Liu K, Luo Y, Kang M, et al
    Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.
    Gastroenterology. 2023;165:88-103.
    PubMed     Abstract available
    
    
    June 2023
33. LIM HYG, Barker N
    Sox9, A Key Regulator of Gastric Stem Cell Behavior Driving Cancer Initiation.
    Gastroenterology. 2023;164:1052-1053.
    PubMed    
    
    
    
34. CHEN Q, Weng K, Lin M, Jiang M, et al
    SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division.
    Gastroenterology. 2023;164:1119-1136.
    PubMed     Abstract available
    
    
    May 2023
35. GLEESON FC, Smyrk TC, Hansel SL
    Diarrhea, Colonic Stenoses, and a Kinase Inhibitor.
    Gastroenterology. 2023;164:e17-e18.
    PubMed    
    
    
    April 2023
36. LI D, Jiang SF, Lei NY, Shah SC, et al
    Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
    Gastroenterology. 2023 Apr 30:S0016-5085(23)00695.
    PubMed     Abstract available
    
    
    March 2023
37. GUO X, Peng Y, Song Q, Wei J, et al
    A liquid biopsy signature for the early-detection of patients with gastric cancer.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00236.
    PubMed     Abstract available
    
    
    
38. MATSUMOTO H, Minaga K, Watanabe T
    Circumferential Gastric Wall Thickening With Lymphadenopathy.
    Gastroenterology. 2023;164:338-339.
    PubMed    
    
    
    February 2023
39. DECOURTYE-ESPIARD L, Guilford P
    Hereditary Diffuse Gastric Cancer.
    Gastroenterology. 2023 Feb 3:S0016-5085(23)00110.
    PubMed     Abstract available
    
    
    
40. RUAN J, Xu J, Mao J
    A 5-Year Follow-Up of a Submucosal Tumor in the Stomach.
    Gastroenterology. 2023;164:e1-e3.
    PubMed    
    
    
    January 2023
41. HUANG RJ, Laszkowska M, In H, Hwang JH, et al
    Controlling Gastric Cancer in a World of Heterogeneous Risk.
    Gastroenterology. 2023 Jan 24:S0016-5085(23)00051.
    PubMed     Abstract available
    
    
    November 2022
42. OMOFUMA OO, Cook MB, Abnet CC, Camargo MC, et al
    Race/Ethnicity, Stage-Specific Mortality and Cancer Treatment in Esophageal and Gastric Cancers: Surveillance Epidemiology and End Results (2000-2018).
    Gastroenterology. 2022 Nov 30:S0016-5085(22)01353.
    PubMed    
    
    
    October 2022
43. SHAH SC
    Improving the Endoscopic Detection and Management of Gastric Intestinal Metaplasia Through Training: A Practical Guide.
    Gastroenterology. 2022;163:806-811.
    PubMed    
    
    
    
44. NAKAYAMA S, Matsumura K, Fukuda A
    A Case of a Gastric Lesion With a Hypoechoic Area in the Submucosa.
    Gastroenterology. 2022;163:828-829.
    PubMed    
    
    
    
45. MIN J, Zhang C, Bliton RJ, Caldwell B, et al
    Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa.
    Gastroenterology. 2022;163:875-890.
    PubMed     Abstract available
    
    
    September 2022
46. YAN L, Ye W
    Reply to Letter to the Editor: Active eradication of Helicobacter pylori within organized massive screening might improve survival of gastric cancer patients (GASTRO-D-22-00967R1).
    Gastroenterology. 2022 Sep 3. pii: S0016-5085(22)01033.
    PubMed    
    
    
    
47. MORSE B, Strosberg J
    Multiple Tumors in a Young Patient.
    Gastroenterology. 2022;163:e13-e15.
    PubMed    
    
    
    August 2022
48. ABIMANSOUR J, Wu TT, Sweetser S
    A Distinct and Potentially Deadly Cause of Gastric Polyposis.
    Gastroenterology. 2022;163:379-381.
    PubMed    
    
    
    
49. DING L, Chakrabarti J, Sheriff S, Li Q, et al
    Toll-like Receptor 9 Pathway Mediates Schlafen(+)-MDSC Polarization During Helicobacter-induced Gastric Metaplasias.
    Gastroenterology. 2022;163:411-425.
    PubMed     Abstract available
    
    
    
50. SENG WPN, Chua HW, Toh BC
    An Unusual Cause of Gastric Outlet Obstruction.
    Gastroenterology. 2022;163:e6-e9.
    PubMed    
    
    
    June 2022
51. JIA Y, Lu Z, Liu D
    Potential effects of FGFR4 in the Helicobacter pylori-induced inflammatory carcinoma transformation.
    Gastroenterology. 2022 Jun 18. pii: S0016-5085(22)00669.
    PubMed    
    
    
    
52. ABIMANSOUR JP, Van Treeck BJ, Chandrasekhara V
    Gastric Polyps in a Patient With Dyspepsia.
    Gastroenterology. 2022;162:1852-1854.
    PubMed    
    
    
    May 2022
53. FORD AC, Yuan Y, Moayyedi P
    Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: A meta-analysis beyond 10 years of follow-up.
    Gastroenterology. 2022 May 19. pii: S0016-5085(22)00518.
    PubMed    
    
    
    
54. ZHANG X, Soutto M, Chen Z, Bhat N, et al
    Induction of FGFR4 by H. pylori via STAT3 with a feedforward activation loop involving SRC signaling in gastric cancer.
    Gastroenterology. 2022 May 16. pii: S0016-5085(22)00505.
    PubMed     Abstract available
    
    
    
55. ZOU JC, Yang Y, Chen XZ
    Active eradication of Helicobacter pylori within organized massive screening might improve survival of gastric cancer patients.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00498.
    PubMed    
    
    
    April 2022
56. LI D
    Understanding the Protective Effect of Helicobacter pylori Eradication on Gastric Cancer after a Quarter Century: New Insights from an Old Trial.
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00451.
    PubMed    
    
    
    
57. DUAN Y, Dou Y, Xu D
    How to better understand the gastric carcinogenesis of Helicobacter pylori?
    Gastroenterology. 2022 Apr 22. pii: S0016-5085(22)00430.
    PubMed    
    
    
    
58. ZWAGER LW, Bastiaansen BAJ, Montazeri NSM, Hompes R, et al
    Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis.
    Gastroenterology. 2022 Apr 15. pii: S0016-5085(22)00366.
    PubMed     Abstract available
    
    
    
59. RUBENSTEIN JH, Evans RR, Burns JA, Arasim ME, et al
    Patients With Adenocarcinoma of the Esophagus or Esophagogastric Junction Frequently Have Potential Screening Opportunities.
    Gastroenterology. 2022;162:1349-1351.
    PubMed    
    
    
    March 2022
60. YAN L, Chen Y, Chen F, Tao T, et al
    Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report from a Randomized Controlled Trial with 26.5 Years of Follow-up.
    Gastroenterology. 2022 Mar 29. pii: S0016-5085(22)00338.
    PubMed     Abstract available
    
    
    
61. HUNG KW, Maratt JK, Cho WK, Shah BJ, et al
    AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia with Helicobacter pylori.
    Gastroenterology. 2022 Mar 22. pii: S0016-5085(22)00285.
    PubMed    
    
    
    
62. BUTT J, Lehtinen M, Ohman H, Waterboer T, et al
    Association of Helicobacter pylori and autoimmune gastritis with stomach cancer in a cohort of young Finnish women.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00263.
    PubMed    
    
    
    
63. EL-OMAR EM
    Genetic Predisposition for Helicobacter pylori Infection-The Jury Is Still Out!
    Gastroenterology. 2022 Mar 9. pii: S0016-5085(22)00233.
    PubMed    
    
    
    February 2022
64. ZHOU CB, Pan SY, Jin P, Deng JW, et al
    Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer.
    Gastroenterology. 2022 Feb 12. pii: S0016-5085(22)00143.
    PubMed     Abstract available
    
    
    
65. CAO L, Zhu S, Lu H, Soutto M, et al
    Helicobacter pylori-induced RASAL2 through activation of NF-kB promotes gastric tumorigenesis via beta-catenin signaling axis.
    Gastroenterology. 2022 Feb 5. pii: S0016-5085(22)00101.
    PubMed     Abstract available
    
    
    
66. TAKAGI K, Kanehira N, Matsumoto K
    A Rare Complication of Barium Swallow Test.
    Gastroenterology. 2022;162:401-403.
    PubMed    
    
    
    January 2022
67. LAM SY, Mommersteeg MC, Yu B, Broer L, et al
    Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers.
    Gastroenterology. 2022 Jan 11. pii: S0016-5085(22)00019.
    PubMed     Abstract available
    
    
    
68. YANG XY, Begin LR, Tamaz R
    A 20-Year-Old-Man With New Onset of Melena.
    Gastroenterology. 2022;162:e14-e15.
    PubMed    
    
    
    December 2021
69. LIABEUF D, Oshima M, Stange DE, Sigal M, et al
    Stem Cells, Helicobacter pylori and Mutational Landscape - Utility of Pre-Clinical Models to Understand Carcinogenesis and to direct Management of Gastric Cancer.
    Gastroenterology. 2021 Dec 20. pii: S0016-5085(21)04088.
    PubMed     Abstract available
    
    
    October 2021
70. HOLMBERG D, Santoni G, Catarina von Euler-Chelpin M, Farkkila M, et al
    Incidence and mortality in upper gastrointestinal cancer after negative endoscopy for gastroesophageal reflux disease.
    Gastroenterology. 2021 Oct 7. pii: S0016-5085(21)03617.
    PubMed     Abstract available
    
    
    
71. FLEISCHMANN C, Probst A, Ebigbo A, Faiss S, et al
    Endoscopic Submucosal Dissection in Europe: Results of 1000 Neoplastic Lesions From the German Endoscopic Submucosal Dissection Registry.
    Gastroenterology. 2021;161:1168-1178.
    PubMed     Abstract available
    
    
    
72. VAN DE BRUAENE C, Hoorens A, de Coninck S
    Heavy on the Stomach.
    Gastroenterology. 2021;161:e7-e8.
    PubMed    
    
    
    September 2021
73. JEONG H, Lee B, Kim KH, Cho SY, et al
    WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
    Gastroenterology. 2021;161:953-967.
    PubMed     Abstract available
    
    
    August 2021
74. RUSTGI SD, Oh A, Hur C
    Testing and Treating Helicobacter Pylori Infection in Individuals with Family History of Gastric Cancer is Cost-effective.
    Gastroenterology. 2021 Aug 27. pii: S0016-5085(21)03440.
    PubMed    
    
    
    
75. DOUCHI D, Yamamura A, Matsuo J, Melissa Lim YH, et al
    Induction of gastric cancer by successive oncogenic activation in the corpus.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03359.
    PubMed     Abstract available
    
    
    April 2021
76. ZHANG X, Zheng H, Hua B
    No Association Between Endoscopic Screening and Gastric Cancer Incidence in Asian Countries.
    Gastroenterology. 2021 Apr 5. pii: S0016-5085(21)00626.
    PubMed    
    
    
    March 2021
77. KODACH LL, Peppelenbosch MP
    Targeting the myeloid-derived suppressor cell compartment for inducing responsiveness to immune-checkpoint blockade is best limited to specific subtypes of gastric cancer.
    Gastroenterology. 2021 Mar 30. pii: S0016-5085(21)00574.
    PubMed    
    
    
    
78. GAO Y, Xi H, Chen L
    Does endoscopic screening really not alter the incidence of gastric cancer?
    Gastroenterology. 2021 Mar 18. pii: S0016-5085(21)00534.
    PubMed    
    
    
    
79. LIN Y, Zheng Y, Wang HL, Wu J, et al
    Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030.
    Gastroenterology. 2021 Mar 17. pii: S0016-5085(21)00531.
    PubMed     Abstract available
    
    
    
80. PIAZUELO MB, Bravo LE, Mera RM, Camargo MC, et al
    The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Gastroenterology. 2021;160:1106-1117.
    PubMed     Abstract available
    
    
    
81. GOBERT AP, Boutaud O, Asim M, Zagol-Ikapitte IA, et al
    Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis.
    Gastroenterology. 2021;160:1256-1268.
    PubMed     Abstract available
    
    
    January 2021
82. TURKINGTON RC, Lavery A, Donnelly D, Cairnduff V, et al
    The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophago-gastric Cancer.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00276.
    PubMed    
    
    
    
83. LEE YC, Chiang TH, Chiu HM, Wu MS, et al
    Community-based Gastric Cancer Screening Coupled with a National Colorectal Cancer Screening Program: Baseline Results.
    Gastroenterology. 2021 Jan 11. pii: S0016-5085(21)00067.
    PubMed    
    
    
    
84. HARVEY JJ, Prentice RE, P'ng CH
    A Remote Cause of Epigastric Pain.
    Gastroenterology. 2021;160:e13-e14.
    PubMed    
    
    
    
85. DE SALVO C, Pastorelli L, Petersen CP, Butto LF, et al
    Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice.
    Gastroenterology. 2021;160:302-316.
    PubMed     Abstract available
    
    
    December 2020
86. BOCKERSTETT KA, Lewis SA, Noto CN, Ford EL, et al
    Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.
    Gastroenterology. 2020;159:2116-2129.
    PubMed     Abstract available
    
    
    November 2020
87. TOGASAKI K, Sugimoto S, Ohta Y, Nanki K, et al
    Wnt Signaling Shapes the Histological Variation in Diffuse Gastric Cancer.
    Gastroenterology. 2020 Nov 17. pii: S0016-5085(20)35404.
    PubMed     Abstract available
    
    
    October 2020
88. KIM W, Chu TH, Nienhuser H, Jiang Z, et al
    PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice.
    Gastroenterology. 2020 Oct 28. pii: S0016-5085(20)35325.
    PubMed     Abstract available
    
    
    July 2020
89. CHONWERAWONG M, Ferrand J, Chaudhry HM, Higgins C, et al
    Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue.
    Gastroenterology. 2020;159:169-182.
    PubMed     Abstract available
    
    
    May 2020
90. DINIS-RIBEIRO M, Kuipers EJ
    How to Manage a Patient With Gastric Intestinal Metaplasia: An International Perspective.
    Gastroenterology. 2020;158:1534-1537.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.